Resin-composite dental cement ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

resin-composite dental cement

the trustee for impulsedent australia t/a impulsedent australia - 35870 - resin-composite dental cement - a non-sterile substance intended for professional use as a resin cement with self cured polymerization. dental restoratiuons can be designed on a gypsum modell before casting. after application, this device cannot be reused.

Dental prosthesis/implant abutment screw ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

dental prosthesis/implant abutment screw

the trustee for impulsedent australia t/a impulsedent australia - 61647 - dental prosthesis/implant abutment screw - this non-sterile device is used for conditionally removable prosthetics and serves to restore the chewing function as a connecting element between primary (e.g. implant) and secondary constructions (e.g. crown, bridge, dentures). if necessary it can be removed and the removable part of the dentures cleaned.

Dental precision attachment, resilient ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

dental precision attachment, resilient

the trustee for impulsedent australia t/a impulsedent australia - 38603 - dental precision attachment, resilient - a dental fixation device designed to give a tooth-borne/tissue-borne prosthesis sufficient mechanical play to withstand the variations in the seating of the prosthesis due to deformation of the underlying tissues, without placing excessive stress on the abutments.

Crown/bridge material, polymer based ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

crown/bridge material, polymer based

the trustee for impulsedent australia t/a impulsedent australia - 38781 - crown/bridge material, polymer based - a dental resin composite material intended to be used for veneering a restorative dental prosthesis (e.g., crown, bridge, fixed or removable denture); some types may be used as stains to apply colour to the dental appliance. after application, this material cannot be reused.

Prosthesis priming agent ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

prosthesis priming agent

the trustee for impulsedent australia t/a impulsedent australia - 62474 - prosthesis priming agent - a material primarily intended to be applied to a dental prosthesis (i.e., indirect restorative) and/or prosthesis component to promote bonding (e.g., to a composite resin cement, composite-based stain, or another prosthesis component)

Dental acrylic resin ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

dental acrylic resin

the trustee for impulsedent australia t/a impulsedent australia - 63591 - dental acrylic resin - a non-sterile substance intended for professional use as a dental cement, luting agent, liner, base, pulp-capping material, pit/fissure sealant, and/or direct dental restorative material, typically for short-term fixed prosthesis use (temporary crowns and bridges used for 6 months or less) or long-term removable prosthesis use. after application, this device cannot be reused.

Dental prosthesis fabrication material, combination-material ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

dental prosthesis fabrication material, combination-material

the trustee for impulsedent australia t/a impulsedent australia - 62817 - dental prosthesis fabrication material, combination-material - a dental material made of a combination of metal, ceramic, and/ or synthetic polimer (e.g., polyethylene pe) intended to be used to manufacture a final dental appliance/prosthesis for patient use.

MYZILRA- levonorgestrel and ethinyl estradiol संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

myzilra- levonorgestrel and ethinyl estradiol

par pharmaceutical - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - levonorgestrel 0.05 mg - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use myzilra® tablets as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and the iud, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. depending on method (calendar, ovulation, symptothermal, post-ovulation) adapted from hatcher ra et al, contraceptive technology: 17th revised edition. ny, ny: ardent media, inc., 1998. oral contraceptives should not be used in women with any of the following conditions: thrombophlebitis or thromboembolic disorders. a past history of deep-vein thrombophlebitis or thromboembolic disorders. cerebral-vascular or coronary-artery disease. known or suspected carcinoma of the breast. carcinoma of

Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

chateal® (levonorgestrel and ethinyl estradiol tablets, usp 0.15 mg/0.03 mg)

rpk pharmaceuticals, inc. - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and the iud, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. na - not available a depending on method (calendar, ovulation, symptothermal, post-ovulation) adapted from hatcher ra et al, contraceptive technology : 17th revised edition . ny, ny: ardent media, inc., 1998. combination oral contraceptives should not be used in women with any of the following conditions: thrombophlebitis or thromboembolic disorders. a past history of deep-vein thrombophlebitis or thromboembolic disorders. cerebral-vascular or coronary-artery disease. thrombogenic valvulopathies

LEVONORGESTREL AND ETHINYL ESTRADIOL- levonorgestrel and ethinyl estradiol tablets संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

levonorgestrel and ethinyl estradiol- levonorgestrel and ethinyl estradiol tablets

xiromed, llc. - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.   oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and the iud, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates.   table ii: percentage of women experiencing an unintended pregnancy during the first year of use of a contraceptive method na – not available   *depending on method (calendar, ovulation, symptothermal, post-ovulation) adapted from hatcher ra et al, contraceptive technology: 17th revised edition . ny, ny: ardent media, inc., 1998 combination oral contraceptives should not be used in women with any of the following conditions:   thrombophlebitis or thromboembolic disorders.   a past history of deep